Global Regenerative Group
Global Regenerative Group is a privately held, Miami-based medical device manufacturer (founded 2014, 11–50 employees) focused on the development, marketing, and finance of regenerative medicine products for clinical and distribution customers.
- Company typePrivate
- Founded2014
- HeadquartersMiami, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Global Regenerative Group does
Global Regenerative Group is a privately held, for-profit medical device manufacturer founded in 2014 and headquartered in Miami, Florida. Per its self-description in firmographic data, the company specializes in the development, marketing, and finance of products in the regenerative medicine category — a segment that spans tissue-engineered, cellular, and biomaterial-based devices typically sold to clinicians, hospitals, and distribution partners.
The company operates with a small team of 11–50 employees and is registered at the domain globalregenerative.group. No product catalog, technology stack, regulatory clearances, certifications, patents, or named customers are documented in the available input. The website itself returned only a loading/verification page with no substantive company content, so specific products, indications, pricing, distribution channels, and go-to-market mechanics cannot be verified from first-party material.
Given the data thinness — no funding rounds, no management team disclosures, no M&A activity, no partnerships, and no revenue figures — the investment-relevant facts that can be stated with confidence are limited to the firmographic profile above. Triangulation on revenue, growth, and competitive positioning therefore relies on headcount and category norms rather than disclosed company metrics, and any deeper claims should be deferred until primary sources (cap table, FDA registrations, customer references) are obtained.
Global Regenerative Group firmographics
Firmographics- Name
- Global Regenerative Group
- Website
- https://globalregenerative.group
- Company type
- Private
- Founded year
- 2014
- Headcount range
- 11–50 employees
- Short description
- Global Regenerative Group is a privately held, Miami-based medical device manufacturer (founded 2014, 11–50 employees) focused on the development, marketing, and finance of regenerative medicine products for clinical and distribution customers.
- Ownership category
- akta.pro rank
Global Regenerative Group industry classification
Industry- Product category
- Regenerative Medicine Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Stem Cell–Based Regenerative Therapies (HLAAAGAA)
- akta.pro secondary industry
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
Keywords
Where Global Regenerative Group is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Markets served
Global Regenerative Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales
Global Regenerative Group product offering
Product offeringCore offering
Global Regenerative Group is a medical device manufacturer focused on the development, marketing, and finance of regenerative medicine products. The company produces and supplies medical devices used in regenerative medicine applications for healthcare providers and clinical practitioners.
Differentiator
Problem solved
Functional benefit
Products and services
- Regenerative Medicine Medical Devices
Companies that use Global Regenerative Group
Customer profileIdeal customer profiles1 record
Global Regenerative Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Global Regenerative Group partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Global Regenerative Group competitors and assessment
Company assessmentBroad incumbents
- Stryker: Diversified medical-device leader with regenerative biologics offerings (e.g., bone-graft substitutes) used in orthopedics; comparable end-markets and hospital procurement motion.
- Smith & Nephew: Global medical-device major with advanced wound management and regenerative product lines; comparable as a broad incumbent competing for the same hospital and clinician budgets.
- Integra LifeSciences: Large diversified medical-device company with a meaningful regenerative tissue and wound-care franchise; comparable as a broader incumbent overlapping Global Regenerative Group's target end markets.
- Coloplast: Global medical-device company with a wound-care and skin-substitute portfolio serving hospitals and home care; comparable as an incumbent in the same downstream end markets.
Emerging players
- Athersys: Clinical-stage regenerative medicine company developing stem-cell therapies for inflammatory and injury indications; comparable as a smaller, R&D-driven regenerative-medicine peer.
- Mesoblast: Cell-therapy and regenerative medicine developer targeting inflammatory and musculoskeletal conditions; comparable technology category, though at a different commercialization stage.
- Pluristem Therapeutics: Clinical-stage regenerative medicine company using placenta-derived cell therapies; comparable as a niche, IP-driven regenerative-medicine developer with overlapping scientific ambitions.
Direct peers
- MiMedx Group: Manufacturer of regenerative medicine products derived from human placental tissue, serving wound care and surgical applications; comparable in product type, customer base, and go-to-market motion.
- Vericel Corporation: Developer of cell-based and regenerative therapies for cartilage repair and burn wounds; directly comparable as a specialty regenerative-medicine manufacturer selling to U.S. hospitals and surgeons.
- Organogenesis Holdings: Public regenerative medicine company focused on skin substitutes and wound-care biologics; directly comparable product category and customer base (hospitals, wound clinics) for a regenerative medicine medical-device manufacturer.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Global Regenerative Group social profiles
Digital presenceGlobal Regenerative Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Global Regenerative Group leadership team
Management profileNumber of profiles
Global Regenerative Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Global Regenerative Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Global Regenerative Group
What does Global Regenerative Group do?
Global Regenerative Group is a medical device manufacturer focused on the development, marketing, and finance of regenerative medicine products. The company produces and supplies medical devices used in regenerative medicine applications for healthcare providers and clinical practitioners.
When was Global Regenerative Group founded?
Global Regenerative Group was founded in 2014. It employs 11 to 50 people.
Where is Global Regenerative Group based?
Global Regenerative Group is headquartered in Miami, United States, in the North America region.
Who are Global Regenerative Group's main competitors?
Broad incumbents on record are Stryker, Smith & Nephew, Integra LifeSciences and Coloplast. Emerging players are Athersys, Mesoblast and Pluristem Therapeutics. Direct peers are MiMedx Group, Vericel Corporation and Organogenesis Holdings.
Does Global Regenerative Group have an API?
No public API is recorded for Global Regenerative Group.
What industry is Global Regenerative Group in?
Global Regenerative Group's product category is Regenerative Medicine Medical Devices. Its primary akta.pro industry code is HLAAAGAA, Stem Cell–Based Regenerative Therapies, with a secondary code of HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts). Its NAICS code is 339112 and its SIC code is 3841.